Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 253, P. 155027 - 155027
Published: Dec. 11, 2023
Language: Английский
Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 253, P. 155027 - 155027
Published: Dec. 11, 2023
Language: Английский
Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 251, P. 154880 - 154880
Published: Oct. 11, 2023
Language: Английский
Citations
16Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 253, P. 155093 - 155093
Published: Jan. 1, 2024
Language: Английский
Citations
6Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 252, P. 154947 - 154947
Published: Nov. 13, 2023
Language: Английский
Citations
16Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 251, P. 154857 - 154857
Published: Oct. 4, 2023
Language: Английский
Citations
15Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2023, Volume and Issue: 397(4), P. 1957 - 1969
Published: Oct. 6, 2023
Language: Английский
Citations
15Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 251, P. 154855 - 154855
Published: Oct. 5, 2023
Language: Английский
Citations
13Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 251, P. 154856 - 154856
Published: Oct. 5, 2023
Language: Английский
Citations
13Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 252, P. 154949 - 154949
Published: Nov. 18, 2023
Language: Английский
Citations
13Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 253, P. 155087 - 155087
Published: Jan. 1, 2024
Language: Английский
Citations
4Non-Coding RNA, Journal Year: 2024, Volume and Issue: 10(5), P. 50 - 50
Published: Sept. 30, 2024
Introduction: Lung cancer remains one of the most prevalent and deadly cancers globally, with high mortality rates largely due to late-stage diagnosis, aggressive progression, frequent recurrence. Despite advancements in diagnostic techniques therapeutic interventions, overall prognosis for lung patients continues be dismal. Method: Emerging research has identified non-coding RNAs (ncRNAs), including microRNAs, long RNAs, circular as critical regulators gene expression, significantly influencing biology. These ncRNAs play pivotal roles various aspects pathogenesis, tumor initiation, metastasis, resistance therapy. Results: We provide a comprehensive analysis current understanding cancer, emphasizing their potential biomarkers early prognostication, prediction response. explore biological functions ncRNAs, involvement key oncogenic pathways, molecular mechanisms by which they modulate expression cellular processes cancer. Furthermore, this review highlights recent advances ncRNA-based tools strategies, such miRNA mimics inhibitors, lncRNA-targeted therapies, circRNA-modulating approaches, offering promising avenues personalized medicine. Conclusion: Finally, we discuss challenges future directions ncRNA research, need large-scale validation studies development efficient delivery systems therapies. This underscores revolutionize management providing novel options that could improve patient outcomes.
Language: Английский
Citations
4